Telehealth and in-person ketamine therapy.
Ketamine is a Schedule III controlled substance. Ketamine clinics and telehealth ketamine platforms need DEA-registered pharmacy fulfillment, state medical licensure in operating states, prescriber DEA registration, and documented clinical protocols. Placement is at acquirers with active controlled-substance underwriting appetite.
DEA registration, controlled substance policy manual, chain-of-custody documentation, diversion prevention protocols, state medical licenses, telehealth platform contracts, fulfillment pharmacy contracts, clinical protocols for depression, PTSD, and off-label indication tracking.
8 to 15 percent rolling at boarding, releasing on 6-month review. Reserve loading reflects the Schedule III regulatory exposure and the higher dispute risk on subscription maintenance protocols.
MCC 8011 or 8099 depending on merchant of record. Pharmacy fulfillment via 5912.